CTAS
27
3
TAP
35
4
NOV
55
-3
GME
55
3
MAS
34
-4
PSA
35
15
GM
57
-6
LB
55
7
AMT
39
3
NTAP
46
3
CSCO
57
3
EXPE
54
-2
HOG
48
3
CA
15
6
VIX
38
-3
BSX
42
2
RHI
40
3
NI
75
3
INTC
61
5
ADBE
44
3
CTAS
27
3
TAP
35
4
NOV
55
-3
GME
55
3
MAS
34
-4
PSA
35
15
GM
57
-6
LB
55
7
AMT
39
3
NTAP
46
3
CSCO
57
3
EXPE
54
-2
HOG
48
3
CA
15
6
VIX
38
-3
BSX
42
2
RHI
40
3
NI
75
3
INTC
61
5
ADBE
44
3
Financhill
Back

Catalyst Pharmaceuticals, Inc. 10K Form

Buy
63

CPRX
Catalyst Pharmaceuticals, Inc.

Last Price:
$24.67
Seasonality Move:
6.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $589M
Cash Flow: $44.9M
Price / Cash Flow: 14.97
Annual Sales: $7.79
Price / Book: 3.14

Profitability

EPS (TTM): 1.68440
Net Income (TTM): $214.3M
Gross Margin: $464.2M
Return on Equity: 25.2%
Return on Assets: 21.9%

Catalyst Pharmaceuticals, Inc. Earnings Forecast

Key Catalyst Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 24 years for CPRX is 78.82%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 29.06% of Gross Profit Margin.
  • The Research & Development expenses have been 2.16% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CPRX is 36.39% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 12 years.

Catalyst Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.08
Quick Ratio: 5.68

Price-to-Earnings

Trailing P/E Ratio: 14.57
Forward P/E Ratio: 7.88

CPRX Technical Analysis vs Fundamental Analysis

Buy
63
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Is Catalyst Pharmaceuticals, Inc. a Buy or a Sell?